Lucchese, Guglielmo
 Distribuzione geografica
Continente #
AS - Asia 1.771
NA - Nord America 653
SA - Sud America 280
EU - Europa 242
Continente sconosciuto - Info sul continente non disponibili 129
AF - Africa 24
OC - Oceania 1
Totale 3.100
Nazione #
SG - Singapore 1.008
US - Stati Uniti d'America 607
HK - Hong Kong 315
CN - Cina 281
BR - Brasile 225
IT - Italia 137
VN - Vietnam 84
BD - Bangladesh 37
DE - Germania 30
AR - Argentina 25
AT - Austria 18
GB - Regno Unito 17
MX - Messico 16
CA - Canada 13
RU - Federazione Russa 12
IN - India 9
ZA - Sudafrica 9
EC - Ecuador 8
NL - Olanda 7
ID - Indonesia 6
IQ - Iraq 6
PY - Paraguay 6
CO - Colombia 5
CR - Costa Rica 5
ES - Italia 5
JP - Giappone 5
FR - Francia 4
MA - Marocco 4
TT - Trinidad e Tobago 4
UZ - Uzbekistan 4
CL - Cile 3
KW - Kuwait 3
PE - Perù 3
TR - Turchia 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
KE - Kenya 2
LY - Libia 2
NP - Nepal 2
PK - Pakistan 2
PL - Polonia 2
TN - Tunisia 2
UY - Uruguay 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HT - Haiti 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SE - Svezia 1
SV - El Salvador 1
UA - Ucraina 1
Totale 2.971
Città #
Hong Kong 315
Singapore 251
Council Bluffs 220
San Jose 116
Beijing 114
Milan 52
Santa Clara 42
Ashburn 28
Ho Chi Minh City 24
Hanoi 22
Rome 19
Los Angeles 18
Nuremberg 18
São Paulo 18
New York 14
Mexico City 9
Vienna 9
Dallas 8
Rio de Janeiro 8
Johannesburg 7
London 7
Belo Horizonte 5
Berlin 5
Brooklyn 5
Charlotte 5
San José 5
Tokyo 5
Bari 4
Buenos Aires 4
Duque de Caxias 4
Frankfurt am Main 4
Orem 4
Phoenix 4
Quito 4
Quận Bốn 4
Tashkent 4
Turin 4
Atlanta 3
Campinas 3
Casablanca 3
Centro Municipality 3
Chennai 3
Chicago 3
Contagem 3
Da Nang 3
Guayaquil 3
Haiphong 3
Itaquaquecetuba 3
Lima 3
Manaus 3
Pescara 3
Petrópolis 3
Piracicaba 3
Quảng Ninh 3
Recife 3
San Francisco 3
Seattle 3
São Bernardo do Campo 3
São Vicente 3
Taranto 3
Thái Bình 3
Amsterdam 2
Aracaju 2
Ascurra 2
Asunción 2
Baghdad 2
Boardman 2
Botucatu 2
Brasília 2
Brescia 2
Buffalo 2
Bắc Ninh 2
Cabo Frio 2
Campo Grande 2
Casamassima 2
Cascavel 2
Chaguanas 2
City of London 2
Curitiba 2
Dhaka 2
Erbil 2
Ferraz de Vasconcelos 2
Fortaleza 2
Guarulhos 2
Houston 2
Jacksonville 2
Joinville 2
Kuwait City 2
Lancaster 2
Las Vegas 2
Manassas 2
Marília 2
Milwaukee 2
Moncton 2
Montevideo 2
Mumbai 2
Ninh Bình 2
Nova Iguaçu 2
Paris 2
Pelotas 2
Totale 1.539
Nome #
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 64
An epitope platform for safe and effective HTLV-1-immunization: Potential applications for mRNA and peptide-based vaccines 55
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein 54
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 52
Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein. 50
Circumscribing the conformational peptide epitope landscape 48
A Systematic Review Focusing on the Link between Engineered Nanoparticles and Neurodegeneration 45
Brain oscillatory processes related to sequence memory in healthy older adults 45
Bacterial peptides are intensively present throughout the human proteome 44
Changes of Cognitive Performances, Fatigue and Health Related Quality of Life in Natalizumab-Treated Relapsing Multiple Sclerosis Patients 44
Clinical applications of DNA microarray analysis 44
Chapter 33 - Impact of COVID-19 on the brain: Antibodies against brain stem antigens 44
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines 44
A peptide link between HCMV infection, neuronal migration, and psychosis 43
A spiking neurocomputational model of high-frequency oscillatory brain responses to words and pseudowords 43
Charting the peptide crossreactome between HIV-1 and the human proteome 42
A peptide talk between JC virus and the human host: from silent infection to autoimmunity 42
Cerebrospinal fluid findings in COVID-19 indicate autoimmunity 42
Natalizumab treatment affects cognitive performances, fatigue and health related quality of life in Relapsing Multiple Sclerosis 42
Reconciling forgetting and memory consolidation: simulating the dissociable effects of neuronal noise levels on cortical memory 40
Comparison of dry and wet electroencephalography for the assessment of cognitive evoked potentials and sensor-level connectivity 39
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response 39
H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment 38
Communicative-pragmatic assessment is sensitive and time-effective in measuring the outcome of aphasia therapy 36
Zusammensetzungen zur Behandlung von COVID-19-assoziierter Autoimmun-Hirnstamm- Enzephalitis 35
Anti-neuronal and anti-mitochondrial autoantibodies are associated with lower functional status and more severe respiratory symptoms in post COVID syndrome 35
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 35
Impact of COVID‑19 emergency on the psychological well‑being of susceptible individuals 34
Geographical variations in sex ratio trends over time in Multiple Sclerosis 34
Electrophysiological correlates of language improvements after intensive language therapy in patients with chronic post-stroke aphasia 34
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons 33
SARS-CoV-2 and Guillain-Barré Syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism 32
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors. 32
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors 31
Does communication make aphasia therapy more efficient?: Evidence from a cross-over randomized controlled trial 31
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 31
Zika virus and autoimmunity: From microcephaly to Guillain-Barre syndrome, and beyond 30
Immune Response Against SARS-CoV-2 30
COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection 30
Verbal Fluency Impairment in Patients with Clinically Isolated Syndrome Suggestive of Multipla Sclerosis 30
Intensive social interaction for treatment of post-stroke depression in subacute aphasia: The CONNECT trial 29
Geographic Differences in the Temporal Trend of Gender Ratio in Multiple Sclerosis 29
EBV-Associated Cancer and Autoimmunity: Searching for Therapies 29
Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes 29
Differential effects of intensive language-action therapy on processing grammatical word class and semantics demonstrated by functional magnetic resonance imaging 29
Peptide matching between Epstein–Barr virus and human proteins 28
Reconciling forgetting and memory consolidation: Simulating the dissociable effects of neuronal noise levels on cortical memory traces in 30th Annual Computational Neuroscience Meeting 28
Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins 28
Natural history of multiple sclerosis: have available therapies impacted long-term prognosis? 28
Gender ratio of Multiple Sclerosis in Italy: geographical distribution and trend over 60 years 27
No human protein is exempt from bacterial motifs, not even one 27
Sex ratio of multiple sclerosis: a comparison of distribution and trend over 60 years among different countries 27
Using language for communication and action makes intensive aphasia therapy more effective: a crossover randomized controlled trial 27
Sentence Construction by Stored-Form Retrieval and by Combination: ERP Evidence for Early and Interactive Processing 27
Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia 27
Epitopes for a 2019-nCoV vaccine 27
EBV and Molecular Mimicry: Therapeutic Implications 26
Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B 26
Confronting JC virus and Homo sapiens biological signatures 26
Relationships between Plasma Osteopontin Levels and Cognitive Performances in Relapsing Multiple Sclerosis: Effect of Natalizumab Treatment 26
Reply concerning the article "Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond" 25
Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical And Meaningful/less Mini-Constructions 25
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude 25
Proteome-guided search for influenza A B-cell epitopes 25
Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry 25
Increasing age at disability milestones among MS patients in the MSBase Registry 25
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 24
Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial 24
Peptidology: short amino acid modules in cell biology and immunology 24
From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between T. gondii and NMDARs as a Potential Mechanistic Link 24
Early and interactive stored-form (symbol) access and combinatorial (rule) processing in constructing constructions: a MMN study 24
PSYCHOLOGICAL GENERAL WELL-BEING, COGNITIVE FAILURE, AND INFLAMMATION BIOMARKERS AMONG WORKERS FOUR MONTHS AFTER A MILD/ASYMPTOMATIC SARS-CoV-2 INFECTION 24
The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond 24
Impact of natalizumab treatment on cognitive performance, fatigue and health-related quality of life in relapsing multiple sclerosis 24
Cytomegalovirus infection: The neurodevelopmental peptide signatures 24
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. 23
Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins 23
How a single amino acid change may alter the immunological information of a peptide 23
Increased recruitment of domain general neural networks in language processing following Intensive Language-Action Therapy – fMRI evidence from people with chronic aphasia 22
Epitopes for a 2019-nCoV vaccine 22
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry 22
Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions 22
West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses 22
Developing an anti-Campylobacter jejuni vaccine 21
Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide 21
The peptide network between tetanus toxin and human proteins associated with epilepsy 21
Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules 21
Massive peptide sharing between viral and human proteomes 21
Peptide sharing between viruses and DLX Proteins: a potential cross-reactivity pathway to neuropsychiatric disorders 21
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study 21
Single amino acid repeats connect viruses to neurodegeneration 20
Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis 19
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome 19
Occupational zoonoses, neurological diseases, and public health: A one health approach 19
Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining 18
Cross-Reactivity as a Mechanism Linking Infections to Stroke 18
Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the Language-associated NMDA 2A protein 18
Treating multiple sclerosis with natalizumab 18
Peptide profiling of the route from Mahoney to Sabin, and return 18
Work Productivity Loss in People Living With Long COVID Symptoms: a good start and a missed opportunity 16
Totale 3.021
Categoria #
all - tutte 16.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025718 0 0 0 104 4 230 48 17 18 65 144 88
2025/20261.888 254 351 250 227 67 61 138 56 203 99 131 51
2026/2027494 107 363 24 0 0 0 0 0 0 0 0 0
Totale 3.100